NQ Hcif GP Ltd

-

Director Information, Funds, Firms

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
NQ Hcif GP Ltd
FirmNovaQuest Capital Management LLC
Addressc/o NovaQuest Capital Management, LLC 4208 Six Forks Road, Suite 920
Raleigh, NC 27609
Source
Associated Funds Form D Role 2011 - 2026 Raised AUM
NovaQuest Capital Management LLC
NovaQuest Co-Investment Fund I LP 021-195929 Executive Officer
80.0 M 194.8 M
NovaQuest Pharma Opportunities Fund III LP 021-150993 Executive Officer
426.1 M
of 500.0 M
48.1 M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Revance Therapeutics Inc RVNC
Stock Option (Right to Buy) · derivative
2015-05-07 Other 8,000 $0.00
Revance Therapeutics Inc RVNC
Stock Option (Right to Buy) · derivative
2015-05-07 Other 8,000 $0.00
Revance Therapeutics Inc RVNC
Stock Option (Right to Buy) · derivative
2014-04-08 Other 8,000 $0.00
Revance Therapeutics Inc RVNC
Stock Option (Right to Buy) · derivative
2014-04-08 Other 8,000 $0.00
Revance Therapeutics Inc RVNC
Series E-5 Convertible Preferred Stock · derivative
2014-02-11 Conversion 500,039
Revance Therapeutics Inc RVNC
Common Stock
2014-02-11 Conversion 2,039,382
Revance Therapeutics Inc RVNC
Warrant to Purchase Common Stock · derivative
2014-02-11 Option exercise 398,717
Revance Therapeutics Inc RVNC
Series E-4 Convertible Preferred Stock · derivative
2014-02-11 Conversion 1,539,343
Revance Therapeutics Inc RVNC
Common Stock
2014-02-11 Option exercise 398,717
Revance Therapeutics Inc RVNC
Common Stock
2014-02-11 Conversion 658,551
Revance Therapeutics Inc RVNC
Convertible Promissory Notes · derivative
2014-02-11 Conversion 658,551
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com